Successful treatment of advanced bisphosphonate-related osteonecrosis of the mandible with adjunctive teriparatide therapy. (Q39889561)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20310042 AND SRC:MED&resulttype=core&format=json

28 January 2020

title

Successful treatment of advanced bisphosphonate-related osteonecrosis of the mandible with adjunctive teriparatide therapy (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20310042 AND SRC:MED&resulttype=core&format=json

28 January 2020

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20310042 AND SRC:MED&resulttype=core&format=json

28 January 2020

Shih-Jung Cheng

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20310042 AND SRC:MED&resulttype=core&format=json

28 January 2020

Jiiang-Huei Jeng

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20310042 AND SRC:MED&resulttype=core&format=json

28 January 2020

Chun-Pin Chiang

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20310042 AND SRC:MED&resulttype=core&format=json

28 January 2020

Sang-Heng Kok

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20310042 AND SRC:MED&resulttype=core&format=json

28 January 2020

author name string

Hon-Ping Lau

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20310042 AND SRC:MED&resulttype=core&format=json

28 January 2020

publication date

22 March 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20310042 AND SRC:MED&resulttype=core&format=json

28 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20310042 AND SRC:MED&resulttype=core&format=json

28 January 2020

volume

33

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20310042 AND SRC:MED&resulttype=core&format=json

28 January 2020

issue

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20310042 AND SRC:MED&resulttype=core&format=json

28 January 2020

page(s)

1366-1371

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20310042 AND SRC:MED&resulttype=core&format=json

Mechanisms of action of bisphosphonates: similarities and differences and their potential influence on clinical efficacy.

28 January 2020

cites work

1 reference

Mechanism of action, pharmacokinetic and pharmacodynamic profile, and clinical applications of nitrogen-containing bisphosphonates

21 January 2018

1 reference

Patients with bisphosphonates-associated osteonecrosis of the jaw have reduced circulating endothelial cells.

21 January 2018

1 reference

Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic

21 January 2018

1 reference

A review of the literature on osteonecrosis of the jaw in patients with osteoporosis treated with oral bisphosphonates: prevalence, risk factors, and clinical characteristics

21 January 2018

1 reference

Osteonecrosis of the jaw and bisphosphonate treatment for osteoporosis

21 January 2018

1 reference

American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaws--2009 update

21 January 2018

1 reference

Oral bisphosphonate-induced osteonecrosis: risk factors, prediction of risk using serum CTX testing, prevention, and treatment

21 January 2018

1 reference

Bisphosphonate-associated osteonecrosis of mandibular and maxillary bone: an emerging oral complication of supportive cancer therapy

21 January 2018

1 reference

Hyperbaric oxygen treatment and bisphosphonate-induced osteonecrosis of the jaw: a case series

21 January 2018

1 reference

Bisphosphonate-associated osteonecrosis of the jaw in patients with multiple myeloma and breast cancer.

21 January 2018

1 reference

Intravenous bisphosphonate-related osteonecrosis of the jaw: bone scintigraphy as an early indicator.

21 January 2018

1 reference

Treating bisphosphonate osteonecrosis of the jaws: is there a role for resection and vascularized reconstruction?

21 January 2018

1 reference

Vascularized fibula flap reconstruction of the mandible in bisphosphonate-related osteonecrosis

21 January 2018

1 reference

Osteonecrosis of the mandible or maxilla associated with the use of new generation bisphosphonates

21 January 2018

1 reference

Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis

21 January 2018

1 reference

Parathyroid hormone and teriparatide for the treatment of osteoporosis: a review of the evidence and suggested guidelines for its use.

21 January 2018

1 reference

Intermittent parathyroid hormone (1-34) treatment increases callus formation and mechanical strength of healing rat fractures

21 January 2018

1 reference

Stimulation of fracture-healing with systemic intermittent parathyroid hormone treatment

21 January 2018

1 reference

New bone formation with teriparatide [human parathyroid hormone-(1-34)] is not retarded by long-term pretreatment with alendronate, estrogen, or raloxifene in ovariectomized rats

21 January 2018

1 reference

Teriparatide reduces bone microdamage accumulation in postmenopausal women previously treated with alendronate.

21 January 2018

1 reference

Treatment of osteoporosis with parathyroid hormone and teriparatide

21 January 2018

1 reference

The use of parathyroid hormone in the treatment of osteoporosis

21 January 2018

1 reference

Hyperbaric oxygen in addition to antibiotic therapy is effective for bisphosphonate-induced osteonecrosis of the jaw in a patient with multiple myeloma

21 January 2018

1 reference

7 January 2021

Effects of daily treatment with parathyroid hormone on bone microarchitecture and turnover in patients with osteoporosis: a paired biopsy study

1 reference

7 January 2021

Mandibular bone formation rates in aged ovariectomized rats treated with anti-resorptive agents alone and in combination with intermittent parathyroid hormone

1 reference

7 January 2021

Intermittent Parathyroid Hormone Administration Stimulates Bone Formation in the Mandibles of Aged Ovariectomized Rats

1 reference

7 January 2021

Suppressed bone turnover by long-term bisphosphonate treatment accumulates microdamage but maintains intrinsic material properties in cortical bone of dog rib

1 reference

7 January 2021

Resolution of bisphosphonate-associated osteonecrosis of the mandible: possible application for intermittent low-dose parathyroid hormone [rhPTH(1-34)]

1 reference

7 January 2021

Identifiers

DOI

10.1002/HED.21380

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20310042 AND SRC:MED&resulttype=core&format=json

release_4etnhfc5jjem5pzzaefgub33ie

28 January 2020

Fatcat ID

0 references

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20310042 AND SRC:MED&resulttype=core&format=json